Exchange Traded Concepts’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.32M | Sell |
295,487
-16,359
| -5% | -$184K | 0.04% | 385 |
|
|
2025
Q1 | $1.78M | Buy |
311,846
+120,572
| +63% | +$687K | 0.03% | 409 |
|
|
2024
Q4 | $1.88M | Sell |
191,274
-175,704
| -48% | -$1.73M | 0.04% | 391 |
|
|
2024
Q3 | $2.99M | Buy |
366,978
+209,104
| +132% | +$1.7M | 0.07% | 233 |
|
|
2024
Q2 | $2.11M | Buy |
157,874
+73,152
| +86% | +$978K | 0.05% | 282 |
|
|
2024
Q1 | $3.93M | Buy |
84,722
+72,027
| +567% | +$3.34M | 0.1% | 192 |
|
|
2023
Q4 | $858K | Buy |
12,695
+2,748
| +28% | +$186K | 0.02% | 436 |
|
|
2023
Q3 | $720K | Buy |
9,947
+8,115
| +443% | +$588K | 0.02% | 451 |
|
|
2023
Q2 | $136K | Buy |
+1,832
| New | +$136K | ﹤0.01% | 872 |
|
|
2022
Q1 | – | Sell |
-1,618
| Closed | -$538K | – | 1244 |
|
|
2021
Q4 | $538K | Buy |
+1,618
| New | +$538K | 0.01% | 655 |
|